Gad Sofer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gad Sofer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gad Sofer. Gad Sofer is Chief Operating Officer in Atara Biotherapeutics, Inc. ($ATRA) and EVP & Chief Strategy Officer in Atara Biotherapeutics, Inc. ($ATRA).
Latest Insider Trading Transactions of Gad Sofer
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 39.85 | 22,158 | 882,996 | 243,966 | 266.1 K to 244 K (-8.33 %) |
| Aug 16 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 35.90 | 382 | 13,714 | 266,124 | 266.5 K to 266.1 K (-0.14 %) |
| May 16 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 45.90 | 382 | 17,534 | 266,506 | 266.9 K to 266.5 K (-0.14 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 2,764 | 0 | 0 | |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 47.05 | 1,456 | 68,505 | 266,888 | 268.3 K to 266.9 K (-0.54 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 2,764 | 0 | 268,344 | 265.6 K to 268.3 K (+1.04 %) |
| Feb 12 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 41.70 | 4,169 | 173,847 | 265,580 | 269.7 K to 265.6 K (-1.55 %) |
| Feb 08 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | A | 35.80 | 35,000 | 1,253,000 | 35,000 | |
| Feb 08 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 35.80 | 3,987 | 142,735 | 269,749 | 273.7 K to 269.7 K (-1.46 %) |
| Feb 08 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Grant | A | 0.00 | 17,500 | 0 | 273,736 | 256.2 K to 273.7 K (+6.83 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 4,146 | 0 | 2,764 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.00 | 7,000 | 105,000 | 256,236 | 263.2 K to 256.2 K (-2.66 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 4,146 | 0 | 263,236 | 259.1 K to 263.2 K (+1.60 %) |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 4,145 | 0 | 6,910 | |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 14.53 | 2,464 | 35,802 | 259,090 | 261.6 K to 259.1 K (-0.94 %) |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 4,145 | 0 | 261,554 | 257.4 K to 261.6 K (+1.61 %) |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.00 | 7,000 | 105,000 | 257,409 | 264.4 K to 257.4 K (-2.65 %) |
| Mar 13 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 20.00 | 2,500 | 50,000 | 266,527 | 269 K to 266.5 K (-0.93 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 4,146 | 0 | 15,201 | |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 9,616 | 0 | 6,410 | |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.62 | 7,273 | 113,604 | 269,027 | 276.3 K to 269 K (-2.63 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 4,146 | 0 | 276,300 | 272.2 K to 276.3 K (+1.52 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 9,616 | 0 | 272,154 | 262.5 K to 272.2 K (+3.66 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.22 | 7,000 | 106,540 | 262,538 | 269.5 K to 262.5 K (-2.60 %) |
| Feb 13 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 16.13 | 400 | 6,452 | 269,538 | 269.9 K to 269.5 K (-0.15 %) |
| Feb 13 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.42 | 5,874 | 90,577 | 269,938 | 275.8 K to 269.9 K (-2.13 %) |
| Feb 08 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Grant | A | 0.00 | 45,000 | 0 | 275,812 | 230.8 K to 275.8 K (+19.50 %) |
| Nov 22 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 18.41 | 1,480 | 27,247 | 230,812 | 232.3 K to 230.8 K (-0.64 %) |
| Nov 16 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,146 | 0 | 19,347 | |
| Nov 16 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,615 | 0 | 16,026 | |
| Nov 16 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 19.27 | 7,136 | 137,511 | 232,292 | 239.4 K to 232.3 K (-2.98 %) |
| Nov 16 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,146 | 0 | 239,428 | 235.3 K to 239.4 K (+1.76 %) |
| Nov 16 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,615 | 0 | 235,282 | 225.7 K to 235.3 K (+4.26 %) |
| Nov 16 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 20.55 | 9,582 | 196,910 | 225,667 | 235.2 K to 225.7 K (-4.07 %) |
| Sep 23 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Grant | A | 0.00 | 90,000 | 0 | 235,249 | 145.2 K to 235.2 K (+61.96 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,145 | 0 | 23,493 | |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,616 | 0 | 25,641 | |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 22.44 | 5,256 | 117,945 | 145,249 | 150.5 K to 145.2 K (-3.49 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 20.95 | 100 | 2,095 | 150,505 | 150.6 K to 150.5 K (-0.07 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,145 | 0 | 150,605 | 146.5 K to 150.6 K (+2.83 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,616 | 0 | 146,460 | 136.8 K to 146.5 K (+7.03 %) |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,146 | 0 | 27,638 | |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,615 | 0 | 35,257 | |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 15.91 | 5,427 | 86,344 | 136,844 | 142.3 K to 136.8 K (-3.81 %) |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,146 | 0 | 142,271 | 138.1 K to 142.3 K (+3.00 %) |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,615 | 0 | 138,125 | 128.5 K to 138.1 K (+7.48 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,146 | 0 | 31,784 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,615 | 0 | 44,872 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 17.13 | 3,783 | 64,803 | 128,510 | 132.3 K to 128.5 K (-2.86 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 16.07 | 1,928 | 30,983 | 132,293 | 134.2 K to 132.3 K (-1.44 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,146 | 0 | 134,221 | 130.1 K to 134.2 K (+3.19 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,615 | 0 | 130,075 | 120.5 K to 130.1 K (+7.98 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Grant | A | 0.00 | 48,447 | 0 | 120,460 | 72 K to 120.5 K (+67.28 %) |
| Dec 21 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | A | 22.72 | 65,000 | 1,476,800 | 65,000 | |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,146 | 0 | 35,930 | |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,616 | 0 | 54,487 | |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 31.69 | 1,644 | 52,103 | 72,013 | 73.7 K to 72 K (-2.23 %) |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 31.09 | 5,942 | 184,743 | 73,657 | 79.6 K to 73.7 K (-7.46 %) |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,146 | 0 | 79,599 | 75.5 K to 79.6 K (+5.49 %) |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,616 | 0 | 75,453 | 65.8 K to 75.5 K (+14.61 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 11.00 | 2,778 | 30,558 | 37,222 | |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,145 | 0 | 40,076 | |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,615 | 0 | 64,103 | |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 49.78 | 3,427 | 170,596 | 65,837 | 69.3 K to 65.8 K (-4.95 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 49.26 | 4,284 | 211,030 | 69,264 | 73.5 K to 69.3 K (-5.82 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 50.00 | 8,778 | 438,900 | 73,548 | 82.3 K to 73.5 K (-10.66 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 11.00 | 2,778 | 30,558 | 82,326 | 79.5 K to 82.3 K (+3.49 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,145 | 0 | 79,548 | 75.4 K to 79.5 K (+5.50 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,615 | 0 | 75,403 | 65.8 K to 75.4 K (+14.62 %) |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | A | 0.00 | 22,111 | 0 | 44,221 | |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | A | 0.00 | 80,128 | 0 | 73,718 | |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Payment of Exercise | F | 37.30 | 48,851 | 1,822,142 | 65,788 | 114.6 K to 65.8 K (-42.61 %) |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 80,128 | 0 | 114,639 | 34.5 K to 114.6 K (+232.18 %) |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 22,111 | 0 | 34,511 | 12.4 K to 34.5 K (+178.31 %) |
Page: 1